ArticleMolecular biology reports2026
The role of circulating MiR-34a-5p and MiR-let7a-5p as a diagnostic tumor markers in breast cancer a cross-sectional analysis.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast cancer (BC) remains a leading cause of malignancy-related deaths in women. underscoring the need for low-cost, fast, sensitive and non-invasive biomarkers. MicroRNAs as a critical regulators of gene expression, with distinct expression profiles linked to tumor genesis. Particularly miR-let7a-5p and miR-34a-5p are circulating molecules with key roles in tumor suppression and proliferation, offering significant diagnostic potential.
objectivesThis exploratory study investigated the expression levels of circulating miRNAs in breast cancer patients and healthy groups and assessed their potential utility as non-invasive diagnostic biomarkers for breast cancer.
methods200 serum samples were used in this analysis, the amount of each miR expression was measured using RT-qPCR and the fold changes were determined by 2^-ΔΔCt. P-values were determined by the t-test. ROC analysis demonstrated significant diagnostic accuracy to identify BC patients.
resultsOur findings indicate that circulating miR-34a-5p and miR-let-7a-5p are significant non-invasive breast cancer biomarkers, both being notably down-regulated in BC patients compared to healthy controls. With lower expression (fold change 0.503 vs. 0.810), superior diagnostic accuracy (AUC 0.8232) and higher (sensitivity 84%), miR-34a-5p outperformed let-7a-5p. No statistically significant association was identified between the studied miRNAs and age, BMI, or ER expression; however, miR-34a-5p demonstrated a weak negative correlation with PR.
conclusionBoth circulating miR-34a-5p and let-7a-5p are significantly down-regulated in BC patients. MiR-34a-5p showed better accuracy on diagnostic performance, indicating its possible value as a promising non-invasive biomarker for the detection of breast cancer. This study explores the potential of these miRs in developing cost-effective strategies for breast cancer detection and risk assessment, monitoring and classification.
Indexed as
Identifiers
42319671What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.